![Hagop Kantarjian: Gamma delta T cells, a novel immunotherapy for AML](https://oncodaily.com/pub/uploads/2023/05/Hagop_Kantarjian__MD-e1713957952522.jpg)
Photo of Dr. Hagop Kantarjian from obroncology.com
Mar 4, 2024, 10:16
Hagop Kantarjian: Gamma delta T cells, a novel immunotherapy for AML
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center,shared a post on X/Twitter:
“Gamma delta T cells are a novel immunotherapy for AML. Recent review from our group. We have clinical trials w Aza Ven and gd2T cell activating ICT01 for Newly Dx AML, & allogeneic gd1T cells for R/R AML”
Source: Hagop Kantarjian/X